The purpose of this study is to see if treatment with atezolizumab and stereotactic body
radiation therapy (SBRT) will improve the objective response rate (ORR) compared with
atezolizumab alone in patients with recurrent, persistent, or metastatic cervical cancer.
Cervical Cancer, Cervical Cancer Recurrent, Cervical Cancer Metastatic
Stereotactic Body Radiation Therapy (SBRT),
Clinical Study Identifier
H. Lee Moffitt Cancer Center and Research Institute
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.